Go to deals
Private Equity | Healthcare

Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital

Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.

Ace Pharmaceuticals is a leading pharmaceutical company in the niche of medical need products, and is based in Zeewolde, the Netherlands. As an independent company, Ace focuses on the development, production and distribution of licensed and unlicensed medicines. With its activities, Ace meets an essential social need: making and keeping scarce medication available for people for whom it is essential. It does so by actively collaborating with relevant stakeholders, including patient associations, doctors and governmental institutions. Since January 2020, Ace has also been supplying pharmaceutical compounding products to pharmacies in the Netherlands through its business unit Ace Compounding.

Oaklins’ debt advisory team in the Netherlands acted as advisor to the consortium and assisted in establishing a financing package aligned with the current business profile and future growth ambitions.

Service
Funding, debt advisory & ECM
Parties
“The COVID-19 pandemic has clearly highlighted the challenges and gaps in our industry in Europe. It makes our mission to make scarce medicines available more important than ever. We want to respond to this situation strongly by growing organically as well as through acquisitions in Europe. With the capital, the know-how and the broad (international) network of Gilde Buy Out Partners, Gilde Healthcare, and our existing investor Quadrum Capital, we can achieve this in both a socially responsible as well as financially sound manner.”

Jan Willem Popma

Director, Ace Pharmaceuticals BV

Talk to the deal team

 Bas  Stoetzer

Bas Stoetzer

Partner

Amsterdam, Netherlands
Oaklins Netherlands
 Jeroen  Derkx

Jeroen Derkx

Director

Amsterdam, Netherlands
Oaklins Netherlands
 Niels  Vermuë

Niels Vermuë

Senior Associate

Amsterdam, Netherlands
Oaklins Netherlands

Related deals

SulAmérica and Rede D’Or São Luiz have announced a combination
Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more
Cyberimpact has been acquired by Oliva Partners
Private Equity | TMT

Cyberimpact has been acquired by Oliva Partners

The founders of Cyberimpact have sold the company to Oliva Partners.

Learn more
Matera has acquired a majority stake in Onidata Tecnologia
Private Equity | Financial Services | TMT

Matera has acquired a majority stake in Onidata Tecnologia

Matera has acquired a majority stake in Onidata Tecnologia.

Learn more